Plasma concentration of matrix metalloproteinase 9 in gastric cancer

British Journal of Surgery

Volumn 84, Issue 1, 1997, Pages 133-136

  Torii, A ^a   Kodera, Y ^a   Uesaka, K ^a   Hirai, T ^a   Yasui, K ^a   Morimoto, T ^a   Yamamura, Y ^a   Kato, T ^a   Hayakawa, T ^b   Fujimoto, N ^c   Kito, T ^a  

^a AICHI CANCER CENTER HOSPITAL   (Japan)

^b AICHI GAKUIN UNIVERSITY   (Japan)

^c FUJI CHEMICAL INDUSTRIES LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE B;

ADULT; ARTICLE; CLINICAL TRIAL; COMPLICATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC VALUE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT CARE; PLASMA; PRIORITY JOURNAL; RECURRENT DISEASE; STOMACH CANCER;

ADULT; AGED; AGED, 80 AND OVER; CARCINOEMBRYONIC ANTIGEN; COLLAGENASES; ENZYME TESTS; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; MALE; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; NEOPLASM METASTASIS; POSTOPERATIVE PERIOD; PREOPERATIVE CARE; SENSITIVITY AND SPECIFICITY; STOMACH NEOPLASMS;

EID: 0009683601     PISSN: 00071323     EISSN: None     Source Type: Journal    
DOI: 10.1002/bjs.1800840147     Document Type: Article

References (25)

1. Tryggvason K, Höyhtyä M, Pyke C. Type IV collagenases in invasive tumors. Breast Cancer Res Treat 1993; 24: 209-18.
2. Liotta LA, Steeg PS, Stetler-Stevenson WG. Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell 1991; 64: 327-36.
3. Ballin M, Gomez DE, Sinha CC. Thorgeirsson UP. Ras oncogene mediated induction of a 92 kDa metalloproteinase: strong correlation with the malignant phenotype. Biochem Biophys Res Commun 1988; 154: 832-8.
4. Wilhelm SM, Collier IE, Marmer BL, Eisen AZ, Grant GA, Goldberg GI. SV40-transformed human lung fibroblasts secrete a 92-kDa type IV collagenase which is identical to that secreted by normal human macrophages. J Biol Chem 1989; 264: 17213-22.
5. Yamagata S, Tanaka R, Ito Y, Shimizu S. Gelatinases of murine metastatic tumor cells. Biochem Biophys Res Commun 1989; 158: 228-34.
6. Mackay AR, Hartzler JL, Pelina MD, Thorgeirsson UP. Studies on the ability of 65-kDa and 92-kDa tumor cell gelatinases to degrade type IV collagen. J Biol Chem 1990; 265: 21 929-34.
7. Moll UM, Youngleib GL, Rosinski KB, Quigley JP. Tumor promoter-stimulated Mr 92000 gelatinase secreted by normal and malignant human cells: isolation and characterization of the enzyme from HT 1080 tumor cells. Cancer Res 1990; 50: 6162-70.
8. Okada Y, Gonoji Y, Naka K et al. Matrix metalloproteinase 9 (92-kDa gelatinase/type IV collagenase) from HT 1080 human fibrosarcoma cells. Purification and activation of the precursor and enzymic properties. J Biol Chem 1992; 267: 21 712-19.
9. Bergmann U, Michaelis J, Oberhoff R, Knauper V, Beckmann R, Tschesche H. Enzyme linked immunosorbent assays (ELISA) for the quantitative determination of human leukocyte collagenase and gelatinase. Journal of Clinical Chemistry, and Clinical Biochemistry 1989; 27: 351-9.
10. Zucker S, Lysik Rm, Gurfinkel M et al. Immunoassay of type IV collagenase/gelatinase (MMP-2) in human plasma. J Immunol Methods 1992; 148: 189-98.
11. Zucker S, Lysik RM, Zarrabi MH, Moll U. M(r) 92000 type IV collagenase is increased in plasma of patients with colon and breast cancer. Cancer Res 1993; 53: 140-6.
12. Fujimoto N, Hosokawa N, Iwata K, Shinya T, Okada Y, Hayakawa T. A one-step sandwich enzyme immunoassay for inactive precursor and complexed form of human matrix metalloproteinase 9 (92 kDa gelatinase/type IV collagenase, gelatinase B) using monoclonal antibodies. Clin Chim Acta 1994; 231: 79-88.
13. Torii A, Nakayama A, Harada A et al. Expression of the CD15 antigen in hepatocellular carcinoma. Cancer 1993; 71: 3864-7.
14. Torii A, Harada A, Nakao AA et al. Expression of HLA-DR in intrahepatic cholangiocarcinoma. Cancer 1992; 70: 1057-61.
15. Kawahara E, Okada Y, Nakanishi I et al. The expression of invasive behaviour of differentiated squamous carcinoma cell line evaluated by in vitro invasion model. Jpn J Cancer Res 1993; 84: 409-18.
16. Hermanek P, Sohin LH, eds. TNM Classification of Malignant Tumours. 4th ed. Berlin: Springer, 1987.
17. Nishi M, Omori Y, Miwa K, eds. Japanese Classification of Gastric Carcinoma. 1st ed. Tokyo: Kanehara, 1995.
18. Kikuchi S, Wada O, Miki K et al. Serum pepsinogen as a new marker for gastric carcinoma among young adults. Research Group on Prevention of Gastric Carcinoma among Young Adults. Cancer 1994; 73: 2695-702.
19. 1) gastric carcinoma and precancerous adjacent mucosa. Gut 1994; 35: 1697-700.
20. Harada H, Tsukada Y, Karasawa Y. Evaluation of tumor-associated antigen (2H6 antigen) in detecting early stage of gastric cancer. Clin Chim Acta 1994; 228: 101-12.
21. Kodera Y, Isohe K, Yamauchi M et al. Expression of carcinoembryonic antigen (CEA) and nonspecific crossreacting antigen (NCA) in gastrointestinal cancer; the correlation with degree of differentiation. Br J Cancer 1993; 68: 130-6.
22. Wobbes T, Thomas CMG, Segers MFG, Nagengast FM. Evaluation of seven tumor markers (CA 50, CA 19-9, CA 19-9 TruQuant, CA 72-4, CA 195, carcinoembryonic antigen, and tissue polypeptide antigen) in the pretreatment sera of patients with gastric carcinoma. Cancer 1992; 69: 2036-41.
23. Nakane Y, Okamura S, Akehira K et al. Correlation of preoperative carcinoembryonic antigen levels and prognosis of gastric cancer patients. Cancer 1994; 73: 2703-8.
24. Danø K, Behrendt N, Brünner N, Ellis V, Ploug M, Pyke C. The urokinase receptor. Protein structure and role in plasminogen activation and cancer invasion. Fibrinolysis 1994; 8: 189-203.
25. Nielsen BS, Timshel S, Kjeldsen L et al. 92 kDa type IV collagenase (MMP-9) is expressed in neutrophils and macrophages but not in malignant epithelial cells in human colon cancer. Int J Cancer 1996; 65: 57-62.